Chronic gonadotropin Market is anticipated to grow at a significant CAGR during the forecast period. The major factor that is expected to boost the market during the forecast period includes the increasing burden of infertility and hypogonadism around the globe. Moreover, increasing awareness about the human chronic gonadotropin (HCG) among healthcare professionals and patients is a major factor that is expected to accelerate the growth of the market during the forecast period. Furthermore, the continuous R&Ds in gonadotropin extraction and preparation, coupled with favorable initiatives by the government and non-government organizations, are the factors that are anticipated to fuel the demand for HCG globally. With the rising demand for assisted reproductive technologies such as in-vitro fertilization (IVF), the demand for human-derived gonadotropins has increased significantly over the years. HCG hormone plays a vital role after the formation of the embryo. Hence, the usage of HCG in infertility treatment is gaining traction in both men and women.
According to the Maternal Health Task Force (MHTF), at least 50 million couples globally experience infertility. The growing burden of infertility around the globe is another factor that is anticipated to propel market growth during the forecast period. In addition, HCG is used as the marker in cancer, including choriocarcinoma, seminoma, germ cell tumors, and others. The chorionic gonadotropin hormone is a placental hormone secreted by syncytiotrophoblast cells during pregnancy. These hormones stimulate the corpus luteum to produce progesterone. Moreover, the naturally extracted or recombinant human chorionic gonadotropin hormones are used in the treatment of infertility, male hypogonadism, and many other conditions. The recombinant chorionic gonadotropin products are expected to have significant growth during the forecast period owing to the availability of different strengths and dosages for the individualization of therapy. This, in turn, is expected to offer an opportunity for the growth of the global chronic gonadotropin market.
To Request a Sample of our Report on Chronic Gonadotropin Market: https://www.omrglobal.com/request-sample/chronic-gonadotropin-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Type
- By Technology
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Merck & Co., Inc., Ferring BV, and Fresenius Kabi AG, among others.
A full Report of Chronic Gonadotropin Market is Available @ https://www.omrglobal.com/industry-reports/chronic-gonadotropin-market
Chronic Gonadotropin Market Report by Segment
By Type
- Human Chronic Gonadotropin
- Animal Chronic Gonadotropin
By Technology
- Female Infertility Treatment
- Oligospermia Treatment
- Cryptorchidism Treatment
- Others
Global Chronic Gonadotropin Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
